TP53 and colorectal carcinoma: To further explore the clinical relevance of RFNG pS255‐regulated p53 phosphorylation, as well as CDKN1A and SLC7A11 protein levels, we collected samples from CRC patients with p53 WT receiving oxaliplatin‐based chemotherapy.